07.07.2017

Transfer of HemoGenix® to Preferred Cell Systems

On June 19, 2017 our Partner HemoGenix® transferred all production and sales of its assay kit and reagents to Preferred Cell Systems.

HemoGenix® is now focussing on its contract research services.

TRINOVA remains the EUROPEAN distributor for the assay kits and reagents;
now for Preferred Cell Systems.

Website Preferred Cell Systems™

Meetings 2018

March 01-03IGLD 2018 Gemeinsames Jahressymposium Frankfurt
March 18-2146th EEMGS/30th GUM Meeting in Potsdam
March 22-23ISBT Cellular Therapies Workshop: Human Platelet Lysate Zurich, Switzerland
September 02-05EUROTOX 2018 Brussels